case_images: PMC11033338_01
case_images: Scrotal ultrasound before targeted therapy (A), scrotal ultrasound after targeted therapy (B), scrotal CT before targeted therapy (C), scrotal CT after targeted therapy (D).
case_images: fonc-14-1358133-g001.jpg
case_images: PMC11033338_01_fonc-14-1358133-g001.jpg
case_images: f1
case_images: Scrotal ultrasound and computed tomography (CT) scans revealed a mass in the right scrotum, raising suspicion of malignancy ( Figure 1 ).
case_images: PET/CT imaging: Testicular before targeted therapy (right), after targeted therapy (left) (A), Inguinal lymph nodes before targeted therapy (right), after targeted therapy (left) (B).
case_images: fonc-14-1358133-g002.jpg
case_images: PMC11033338_01_fonc-14-1358133-g002.jpg
case_images: f2
case_images: The tumor activity in the right scrotal lesion was still present but showed improvement compared to previous scans; B) The previously identified metastatic lymph nodes showed no tumor activity; C) No new lesions were observed ( Figure 2 ). These findings suggested a favorable response to targeted therapy, paving the way for curative surgery.
case_images: The visible component in the image resembles adenocarcinoma of the rete testis (AORT).
case_images: fonc-14-1358133-g003.jpg
case_images: PMC11033338_01_fonc-14-1358133-g003.jpg
case_images: f3
case_images: The postoperative pathological evaluation indicated: 1) Both tumors were of the same origin; 2) Considering the clinical and imaging findings, excluding metastasis from ccRCC, the diagnosis was determined as AORT ( Figure 3 ).